Found: 75
Select item for more details and to access through your institution.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
- By:
- Publication type:
- Article
A Case Report Presenting an Undifferentiated Pancreatic Carcinoma with Osteoclastic-Like Giant Cells with an Unusual Indolent Course.
- Published in:
- American Journal of Case Reports, 2019, v. 20, p. 1750, doi. 10.12659/AJCR.916810
- By:
- Publication type:
- Article
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical and Immunologic Basis of Interferon Therapy in Melanoma.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1182, n. 1, p. 47, doi. 10.1111/j.1749-6632.2009.05073.x
- By:
- Publication type:
- Article
Physics of the sapphire whispering-gallery-mode solid-state MASER oscillator.
- Published in:
- European Physical Journal - Applied Physics, 2020, v. 91, n. 3, p. 1, doi. 10.1051/epjap/2020200107
- By:
- Publication type:
- Article
Photoacoustic detection of circulating melanoma cells in late stage patients.
- Published in:
- Journal of Innovative Optical Health Sciences, 2020, v. 13, n. 6, p. N.PAG, doi. 10.1142/S1793545820500236
- By:
- Publication type:
- Article
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 17, p. 1744, doi. 10.1001/jama.2014.13943
- By:
- Publication type:
- Article
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 8167, doi. 10.3390/ijms24098167
- By:
- Publication type:
- Article
Cutaneous melanoma: A model to study cancer metastasis.
- Published in:
- Journal of Surgical Oncology, 2011, v. 103, n. 6, p. 538, doi. 10.1002/jso.21816
- By:
- Publication type:
- Article
Systemic adjuvant therapy for high-risk cutaneous melanoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221134087
- By:
- Publication type:
- Article
ASO Visual Abstract: Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 6978, doi. 10.1245/s10434-021-10570-5
- By:
- Publication type:
- Article
Comparing the rate of immunotherapy treatment change due to toxicity by sex.
- Published in:
- Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1932
- By:
- Publication type:
- Article
Uveal Melanoma Metastatic to the Liver: Treatment Trends and Outcomes.
- Published in:
- Ocular Oncology & Pathology, 2019, v. 5, n. 5, p. 323, doi. 10.1159/000495113
- By:
- Publication type:
- Article
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 1, p. 183, doi. 10.1007/s11136-022-03226-8
- By:
- Publication type:
- Article
Cutaneous melanoma: available therapy for metastatic disease.
- Published in:
- Dermatologic Therapy, 2006, v. 19, n. 1, p. 19, doi. 10.1111/j.1529-8019.2005.00052.x
- By:
- Publication type:
- Article
Neoadjuvant Therapy in Melanoma: Where Are We Now?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 4, p. 325, doi. 10.1007/s11912-023-01369-6
- By:
- Publication type:
- Article
Adjuvant Therapy for Melanoma.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 5, p. 1, doi. 10.1007/s11912-017-0594-5
- By:
- Publication type:
- Article
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 1, p. 77, doi. 10.1002/mc.23442
- By:
- Publication type:
- Article
Multidisciplinary Care of BRAF‐Mutant Stage III Melanoma: A Physicians Perspective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1644, doi. 10.1002/onco.13852
- By:
- Publication type:
- Article
Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New Rash.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 4, doi. 10.1634/theoncologist.2018-0434
- By:
- Publication type:
- Article
Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1044587
- By:
- Publication type:
- Article
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087705
- By:
- Publication type:
- Article
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1723, doi. 10.1002/cncr.34716
- By:
- Publication type:
- Article
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A four-marker signature of TNF-RII, TGF-alpha, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-19
- By:
- Publication type:
- Article
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Neoadjuvant therapy of locally/regionally advanced melanoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919866959
- By:
- Publication type:
- Article
Neoadjuvant therapy of locally/regionally advanced melanoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919866959
- By:
- Publication type:
- Article
RENORMALIZATION RUNNING OF MASSES AND MIXINGS IN UED MODELS.
- Published in:
- Modern Physics Letters A, 2013, v. 28, n. 11, p. -1, doi. 10.1142/S0217732313300073
- By:
- Publication type:
- Article
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245287
- By:
- Publication type:
- Article
Update on Adjuvant Therapy in Late-Stage Resected Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 753
- By:
- Publication type:
- Article
Prognostic significance of autoimmunity during treatment of melanoma with interferon.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 385, doi. 10.1007/s00281-011-0247-y
- By:
- Publication type:
- Article
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase 2, Randomized Study of SB-485232, rhIL48, in Patients With Previously Untreated Metastatic Melanoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 4, p. 859, doi. 10.1002/cncr.24100
- By:
- Publication type:
- Article
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Safety and Efficacy of Arsenic Trioxide for Patients With Advanced Metastatic Melanoma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 5, p. 1131, doi. 10.1002/cncr.23284
- By:
- Publication type:
- Article
Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Immunotherapy of cancer in 2012.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 309, doi. 10.3322/caac.20132
- By:
- Publication type:
- Article
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
- Published in:
- BMC Bioinformatics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12859-023-05393-y
- By:
- Publication type:
- Article
Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
- Published in:
- Lasers in Surgery & Medicine, 2021, v. 53, n. 4, p. 578, doi. 10.1002/lsm.23286
- By:
- Publication type:
- Article
The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats.
- Published in:
- Phytotherapy Research, 2005, v. 19, n. 3, p. 222, doi. 10.1002/ptr.1661
- By:
- Publication type:
- Article
Higgs quartic coupling and neutrino sector evolution in 2UED models.
- Published in:
- European Physical Journal C -- Particles & Fields, 2014, v. 74, n. 5, p. 1, doi. 10.1140/epjc/s10052-014-2893-4
- By:
- Publication type:
- Article
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors †.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4913, doi. 10.3390/cancers15204913
- By:
- Publication type:
- Article
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4125, doi. 10.3390/cancers15164125
- By:
- Publication type:
- Article
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3180, doi. 10.3390/cancers15123180
- By:
- Publication type:
- Article
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2561, doi. 10.3390/cancers15092561
- By:
- Publication type:
- Article